Offering a combination of simplified and personalized scanning for patients at significantly lower lifecycle costs than other dual-source CT systems, the Somatom Pro.Pulse may be a viable option for smaller rural facilities and outpatient imaging centers.
Noting that initial imaging sensitivity is a key factor in cost-effectiveness for patients who do not require acute treatment for dizziness, researchers found that specialized MRI (including multiplanar high-resolution DWI) provided the most benefit in a comparative trial of neuroimaging modalities.
The Rapid SDH module on the RapidAI platform reportedly offers a sensitivity rate of 93 percent for detection of hemispheric subdural hematoma on non-contrast computed tomography (CT) scans.
Featuring 12 prior FDA clearances for chest X-ray and non-contrast head CT, the Annalise Triage platform may help streamline radiology workflows and prioritize timely diagnosis of urgent conditions.
In a recent video interview series, Dushyant Sahani, M.D., discussed the critical role of contrast media in diagnostic imaging, lessons learned from the contrast media shortage, key considerations with generic agents and currently unmet needs with contrast agents.
Catch up on the top radiology content of the past week.
Photon-counting computed tomography (PCCT) offers a number of salient advantages over conventional CT, including improved image resolution and contrast-to-noise ratio, enhanced denoising capability and inherent spectral sensitivity.
Catch up on the top radiology news of the past week.
Over 80 percent of head and neck computed tomography angiography (CTA) exams performed in the emergency department had no actionable findings for patients with non-focal neurologic complaints, and 67 percent of the exams were ordered by non-physician practitioners (NPPs), according to a newly published study.
Catch up on the top radiology content of the past week.
In a recent video interview, Vivek Bansal, M.D., discussed a recent Radiology Partners publication that offers practical tips and best practice guidance on CT and MRI neuroimaging for stroke patients.
Indicated for the triage and notification of obstructive hydrocephalus on non-contrast brain computed tomography (CT), the artificial intelligence (AI)-enabled software is reportedly the first radiology triage modality to obtain the Food and Drug Administration’s (FDA) Breakthrough Device Designation.
Catch up on the top radiology content of the past week.
Catch up on the top AI-related news and research from the past month.
Superfluous pan scans have become standard for a vast majority of minor injury presentations in emergency room settings.
The use of contrast-enhanced computed tomography (CECT) was associated with more than double the risk of contrast-induced acute kidney injury (CI-AKI) in patients with diabetes and an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2 in comparison to the use of non-contrast CT in this population.
Precision DL, a deep learning-based software which will be available on GE HealthCare’s Omni Legend PET/CT device, reportedly increases the detectability of small, low-contrast lesions by 42 percent.
Review the case study and test your knowledge to make the correct diagnosis.
Catch up on the top AI-related news and research from the past month.
In a subgroup analysis of patients with intracerebral hemorrhage who had intraventicular hemorrhage (IVH) growth, researchers found that hypodensities on non-contrast computed tomography (CT) were associated with more than double the risk for greater than 1 mL of expanded IVH (eIVH).
Catch up on the top radiology content of the past week.
Unvaccinated people with COVID-19 who undergo angiographic reperfusion after acute ischemic stroke may have a greater than fivefold risk of continued infarct growth in comparison to unvaccinated people without COVID-19, according to computed tomography perfusion (CTP) and magnetic resonance imaging (MRI) findings from a recently published study.
The artificial intelligence (AI)-enabled CT 3500 system reportedly reduces patient positioning time by 23 percent, improves low-contrast detectability by 60 percent and facilitates up to an 80 percent reduction in radiation dosing.
Catch up on the top radiology content of the past week.
Revising a March 2022 recommendation, the Food and Drug Administration (FDA) said thyroid monitoring for young children three years of age and under receiving iodinated contrast media (ICM) in relation to contrast-enhanced computed tomography (CECT) can now be reserved for those with risk factors including prematurity, low birth weight or conditions affecting thyroid function.
